sarepta therapeutics inc
(SRPT:Consolidated Issue Listed on NASDAQ Global Select )
Christopher Nishan Garabedian
Chief Executive Officer, President and Director, Sarepta Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 6 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Christopher Nishan Garabedian, also known as Chris, has been the Chief Executive Officer and President of Sarepta Therapeutics, Inc. (alternatively AVI Biopharma Inc) since January 1, 2011. Mr. Garabedian served as Vice President of Corporate Strategy at Celgene Corporation since July 2007. From November 2005 to June 2007, he served as an Independent Consultant to early-stage biopharmaceutical companies. From 1997 to November 2005, he served at Gilead Sciences, Inc., ...
215 First StreetPhone: 857-242-3700
Cambridge, Massachusetts 02142
Board Members Memberships*
Chief Executive Officer, President and Director
University of Maryland
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|William A. Carter M.D.||Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee|
Hemispherx Biopharma, Inc.
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Friedhelm Blobel Ph.D.||Chief Executive Officer, President, Executive Director and Member of Business Development Committee|
SciClone Pharmaceuticals, Inc.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|3.0M GBP||Compensation as of Fiscal Year 2013.|